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Bariatric surgery can facilitate weight loss and improvement in medical co-morbidities. It has a 
profound impact on nutrition and patients need access to follow-up and aftercare. NICE CG189 
Obesity emphasised the importance of a minimum of two years follow-up in the bariatric surgical 
service and recommended that following discharge from the surgical service, there should be annual 
monitoring as part of a shared care model of chronic disease management. 
Methods 
NHS England Obesity Clinical Reference Group commissioned a multi-professional subgroup, which 
included patient representatives, to develop bariatric surgery follow-up guidelines. Terms of 
reference and scope were agreed. The group members took responsibility for different sections of 
the guidelines depending on their areas of expertise and experience.  The quality of the evidence 
was rated and strength graded.  
Results 
Four different shared care models were proposed taking into account of variation in access to 
bariatric surgical services and specialist teams across the country.  The common features include 
annual review, ability for GP to refer back to specialist centre, submission of follow-up data to the 
national data base to NBSR. 
Conclusion 
Clinical commissioning groups need to ensure that a shared care model is implemented as patient 





Guidelines for the follow-up of patients 
undergoing bariatric surgery 
Introduction 
Bariatric surgery is a recognised treatment option for patients with clinically severe obesity. For 
some patients, it is an effective tool in combination with dietary, behavioural and lifestyle changes in 
facilitating weight loss and improvement in medical co-morbidities. The UK National Bariatric 
Surgery Registry (NBSR 2014) reported that between 2011 to 2013, 32,073 bariatric surgery 
operations were performed of which 76.2% were funded by the NHS (1). These included gastric 
band, gastric bypass, sleeve gastrectomy and duodenal switch. One year following surgery, in 
addition to achieving a clinically significant weight loss, 64% of the patients with preoperative 
functional impairment could climb three flights of stairs without resting and 61% of patients who 
had sleep apnoea could stop treatment. Two years after surgery, 65.1% of patients with type 2 
diabetes who had been able to stop hypoglycaemic medication after surgery had not yet needed to 
restart. 
The NCEPOD report Too Lean a Service (2012) was critical of the initial post-operative care and made 
a number of recommendations (2). These included ensuring that the patient received clear post-
operative dietary guidance; the General Practitioner (GP) received a timely discharge summary and 
plan and there was a clear, continuous long term follow-up plan involving all the appropriate health 
care professionals. 
The NICE Clinical Guideline 189 “Obesity: identification, assessment and management of overweight 
and obesity in children, young people and adults” emphasised the importance of regular post-
operative follow-up with a minimum of two years in the bariatric surgical service (3). It was 
recommended that this follow-up should include dietary and nutritional assessment, advice and 
support; nutritional monitoring; review of co-morbidities and medications; physical activity advice 
and support and individualised psychological support. It also stated that following discharge from 
the bariatric surgical service, “there should be at least annual monitoring of nutritional status and 
appropriate supplementation according to need following bariatric surgery, as part of a shared care 
model of chronic disease management”. Currently there is no mechanism as to how this should be 
implemented and there are concerns raised by some GPs with respect to their expertise, facilities 
and resources to do this. 
Bariatric surgery has profound effects on dietary and nutritional intake with some procedures 
affecting the absorption of micronutrients (4-11). There is a serious risk of malnutrition if the patient 
is unable to comply with the nutritional guidelines, follow-up and aftercare. Patients may be at risk 
of protein malnutrition. Although the risk of protein malabsorption is more commonly associated 
with malabsorptive surgical procedures such as the duodenal switch and the distal gastric bypass, 
health care professionals should be aware that all post-operative patients are at risk of developing 
primary protein malnutrition because of poor protein intake. Factors affecting the quality of oral diet 
and nutrition include an overtight gastric band, anastomotic stricture, fear of weight regain, 
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anorexia, vomiting or non-compliance with dietary advice (12). The incidence of iron deficiency 
anaemia and vitamin B12 deficiency is increased following gastric bypass, sleeve gastrectomy and 
duodenal switch (7-11). Vitamin D deficiency is common in the obese population and the risk 
increases following bariatric surgery (13). Patients who undergo a duodenal switch are at additional 
risk of developing deficiencies in fat soluble vitamins and protein (11, 14). Nutritional deficiencies 
are not an inevitable outcome of bariatric surgery and can be avoided with provision of the correct 
aftercare combined with patient compliance. 
The British Obesity and Metabolic Surgery Society (BOMSS) has produced “Guidelines on 
perioperative and postoperative biochemical monitoring and micronutrient replacement for patients 
undergoing bariatric surgery” and “GP Guidance: Management of nutrition following bariatric 
surgery” (15-16). The Royal College of General Practitioners has produced “Ten top tips for the 
management of patients post bariatric surgery in primary care” (17). These have been well received 
and stimulated debate about the aftercare of patients. Whilst there are national and international 
guidelines (7-8, 12, 15, 18-20), there is no clear agreed plan for the management of these patients in 
the long term within the setting of the National Health Service. With the devolvement of 
commissioning of treatment for sever and complex obesity, including bariatric surgery, there is a 
need to develop safe pathways for the care of post-operative bariatric patients. 
Data on obesity patients after surgery is limited as bariatric surgeons are only required to provide 
information to NSBR for 2 years. Subsequently, when patients are no longer under the bariatric 
surgeon, long term data are poorly collected. 
Ongoing research studies may contribute to future practice including the follow-up of bariatric 
surgery patients; these include The SurgiCal Obesity Treatment (SCOTS) Study and the By-Band-
Sleeve Study (21, 22). SCOTS is a 10 years longitudinal study following all patients undergoing 
bariatric surgery in Scotland (21). A wide range of outcomes including mortality, diabetes, 
complications, weight change, nutrition and quality of life will be measured. It is expected that the 
results will be available by 2026. The By-Band-Sleeve Study being conducted in Bristol, UK is a multi-
centre randomised controlled trial designed to compare gastric band, gastric bypass and sleeve 
gastrectomy procedures (22). Outcomes measures will include complications, weight changes, 
nutrition and quality of life measures. The results of this study are expected in 2025. 
This guideline is the first to outline the operational requirements and pathways for long term care of 
patients who undergo obesity surgery. 
Scope  
Aims and objectives of service 
Aim 
• Improve follow-up and aftercare to patients undergoing bariatric surgery 
• Ensure that the best clinical outcomes are achieved 
• Enable patients to have access to appropriate monitoring and aftercare 






• Robust follow-up and aftercare of patients including timely support from the appropriate 
healthcare professionals 
• Long term nutritional monitoring and appropriate interventions 
• Timely access to psychological support as and when needed 
• Good communication between the bariatric surgery providers, GPs  and Tier 3 specialist 
medical obesity services 
• Empowering the patient by providing more awareness of their new body physiology 
following bariatric surgery and to take a lead in self-care with the help of professionals. 
• Patient education including: importance of maintaining optimum bone and neuronal 
metabolism with advancing age - both affected adversely in poorly optimized patients post 
bariatric surgery; role of physical activity; weight maintenance. 
• Information about professionally-led or peer-support groups 
• GP education 
• Monitoring/recall systems/collection of data for NBSR and review of that data. 
Methods 
NHS England Obesity Clinical Reference Group (CRG) commissioned a subgroup to develop bariatric 
surgery follow-up guidelines. The membership included health professionals (surgeon, dietitian, 
nurse and physician) experienced in obesity and bariatric surgery, general practitioners, patient 
representatives and a public health doctor. The group agreed terms of reference and scope. The 
group members took responsibility for different sections of the guidelines depending on their areas 
of expertise and experience with bariatric surgery patients. The quality of evidence was rated and 
the strength of the recommendations graded using graded ‘‘Grading of Recommendations 
Assessment, Development, and Evaluation’’ (GRADE) approach (23).   Where guidance has been 
provided by NICE or NCEPOD, we have adopted their recommendations. All drafts were circulated. 
Feedback from the subgroup was given at a CRG meeting. There was wide consultation with the 
Obesity CRG members.  
Service description/care pathway 
The service pathway covers the following stages: 
1. Immediate postoperative care  
2. Follow-up by the bariatric surgical service  
3. Long term follow-up 
Immediate postoperative care 
The majority of gastric band surgery is day case. There has been a significant reduction in the 
inpatient stay following gastric bypass and sleeve gastrectomy surgeries to 1-2 days. Duodenal 
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switch patient may stay 4-5 days. Patients should be nursed in a high dependency unit or on a 
surgical ward according to their post-operative needs.  
A track and trigger system should be implemented to manage patients on the wards (1, 24). 
Monitoring of the cardiovascular and respiratory status is essential in the postoperative period. 
Identifying early signs and symptoms of complications, including pain, vomiting, tachycardia, 
tachypnoea, hypotension, chest and calf pain, and shortness of breath, acting on them and 
escalating care to the surgical team are vital skills of the nursing staff managing the bariatric surgical 
patient. 
 
Recommendation: A track and trigger system should be implemented to manage patients on the 
wards outside of critical care. 
Evidence: NICE recommendation 
 
Nursing staff should be trained to monitor for postoperative complications including leaks, 
haemorrhage, DVT/PE, sepsis, wound infections and respiratory and cardiovascular complications.  
Other aspects of nursing care to monitor include the management of diabetes, hypertension and 
obstructive sleep apnoea. Patients on CPAP should resume use post-surgery as instructed by 
surgeon. This should be clearly documented. 
Most UK bariatric surgical dietitians educate their patients preoperatively with respect to 
postoperative diet requirements so that patients are fully versed with what they can, and cannot, 
eat at the time of discharge. This should be supported by clearly written postoperative dietary 
guidelines tailored to the patient’s needs (2-3, 7-8, 12). Educating the patient pre-operatively 
negates the need for the patient to see the dietitian prior to discharge.  
Recommendation: Patients should receive a consultation with a specialist dietitian regarding diet 
and food progression.  
Evidence: GRADE B 
 
A pharmacist with experience in bariatric surgery should review medications and can advise on 
converting the patient’s usual medication into a form that can easily be tolerated, and remains safe 
and effective post-surgery, e.g. liquid equivalents, medications that can be crushed and capsules 
that can be opened with the avoidance of effervescent and sugary preparations. (Many bariatric 
surgical services recommend that all medication should be in a soluble, crushable or liquid form for a 
period of 4 to 6 weeks)(25). 
Recommendation: A pharmacist with experience in bariatric surgery should review medications prior 
to surgery and advise on converting the patient’s usual medication into a form that can easily be 
tolerated post-surgery and remains clinically effective  




Bariatric surgery is usually performed laparoscopically so avoiding large painful laparotomy wounds. 
Analgesia should follow the usual pain relief ladder with a combination of analgesics working via 
different pain pathways. Some more complex patients are already on opiates prior to surgery and 
they need special consideration and counselling preoperatively so they have realistic pain control 
expectations.  
Patients should be assessed after surgery for the long term continuation of medication for diabetes 
and hypertension. These medications may require complete cessation or dose modifications in the 
immediate postoperative period (with regular monitoring of blood pressure (BP) and capillary or 
venous glucose) to prevent postural hypotension and hypoglycaemia respectively (26). All other 
medications need to be taken with dose modifications if required. However, it should be made clear 
to patients and all caring teams that type 2 diabetes relapses in a proportion of patients with time 
and, moreover, the effect of weight loss on hypertension is variable, incomplete and often 
temporary (27). 
Patients with diabetes need clear guidance with respect to the reduction and/or cessation of their 
hypoglycaemic medication(s) over time. The patient should be reviewed by a diabetes specialist 
nurse, diabetes or bariatric physician prior to discharge. Patients should be empowered to check 
their blood glucose level regularly and adjust their medication appropriately.  Instructions on 
changes made prior to discharge, and the ongoing need to regularly monitor and modify medication 
should be clearly documented in the discharge summary and communicated to the GP. 
Anti-hypertensive medication should be reviewed, and may need adjusting, including reviewing the 
formulation. 
Recommendation: Antihypertensive and diabetes related medications may be stopped or dose 
modified in the immediate postoperative period (with regular monitoring of BP and blood glucose). 
Other medications may need dose modification. 
Patients with diabetes need clear guidance with respect to the reduction and/or cessation of their 
diabetic medication including the advised time period and review by a diabetic specialist nurse, 
diabetes or bariatric physician. 
Evidence: GRADE D 
 
There is no UK wide consensus with respect to the best venous thromboembolism (VTE) prophylaxis 
regimen (28), but many units will teach patients to self-administer subcutaneous heparin (or 
equivalent) for 7-14 days post-surgery. Patients are supplied with prepared syringes and a sharps 
box.  
All patients should be supplied with graduated compression stockings (unless contraindicated) and 
intermittent pneumatic compression (IPC) devices. Early mobilisation, breathing exercises and 
coughing, and involvement of the bariatric physiotherapists to review patients on the ward post-
surgery is encouraged. The wearing of anti-thrombotic stockings is encouraged, but it is recognised 
that many patient cannot get appropriately sized stockings to fit or they are worn incorrectly (28).  
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Recommendation: VTE prophylaxis for 7-14 days post-surgery.  
All patients should be supplied with graduated compression stockings (unless contraindicated) and 
intermittent pneumatic compression (IPC) devices.  
Evidence: NICE recommendation  
 
Patients with known obstructive sleep apnoea (OSA) should bring their CPAP or BIPAP devices in 
with them for surgery and continue to use it for 3 - 6 months post-surgery. There is robust evidence 
that CPAP pressure requirement is markedly reduced or there is complete resolution of OSA 
following bariatric surgery induced weight loss (29-30). However there is no clear evidence when it is 
safe to return their devices to their local respiratory team;  therefore patients should be reviewed by 
the respiratory physician who will determine whether the BIPAP /CPAP pressures need to be 
adjusted and when a further sleep-respiratory assessment should be undertaken.  
Recommendation: Patients with known obstructive sleep apnoea should be asked to bring their 
CPAP or BIPAP device in with them for surgery and recommended to continue using them for 3 - 6 
months post-surgery. Patients should be reviewed by the respiratory physician as the BIPAP /CPAP 
pressures may need to be adjusted and a further sleep-respiratory assessment undertaken. 
Evidence: GRADE D  
 
Wounds should be assessed and redressed on the ward.  Skin staples, if used, can be removed at 10-
14 days by the practice nurse; most surgeons use subcuticular self-dissolving sutures or skin glue.  A 
letter of instruction is to be given to the patient on discharge for the practice nurse and clearly 
documented in the discharge summary. 
Patients are advised not to get pregnant within eighteen months following bariatric surgery due to 
potential adverse consequences both to the mother and the foetus (26, 30).Those who are of child 
bearing age and sexually active are encouraged to use appropriate non-oral contraception (implant, 
intra-uterine or barrier). The approaches are believed to be the best because of the potential for 
vomiting or diarrhoea after surgery and impaired absorption of oral contraception in malabsorptive 
and restrictive procedures (7-8, 32).  
Recommendation: Women are advised not to get pregnant within eighteen months following 
bariatric surgery. Appropriate non oral contraception should be considered (implant, coil or barrier 
are believed to be the best because of vomiting or diarrhoea and impaired absorption). 
Evidence: GRADE C 
 
Patients should be given the contact details of the dietitian, bariatric specialist nurse and an 
emergency contact number on discharge. 
To facilitate seamless care, a printed discharge summary, including the postoperative discharge plan, 
must be provided to the GP within 24 hours (2). This should state all medications including vitamins 
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and mineral supplements, changes in mode of delivery and potential surgical and medical 
complications in the immediate postoperative period.  
The bariatric surgery team should arrange a follow-up telephone call with the patient within seven 
days of surgery (2).  
Recommendation: A comprehensive written discharge summary including the postoperative 
discharge plan needs to be provided to the GP within 24 hours. 
The bariatric surgery team should arrange a follow-up telephone call with the patient within seven 
days of surgery. 
Evidence: NCEPOD recommendation 
 
Bariatric surgery centre follow-up (first two years) 
All bariatric surgery teams should follow-up patients by telephone and in person at regular intervals 
post-surgery and offer a minimum of two year follow-up (3, 7-8, 15-16). Access should be available 
to the appropriate healthcare professionals including surgeon, dietitian and nurse. The team should 
assess whether input from a bariatric physician and clinical psychologist/psychiatrist is required and 
access provided if needed. 
Patients should be well supported to meet the demands and issues that follow bariatric surgery. This 
includes managing the metabolic changes and dietary changes. The frequency of follow-up will be 
determined by the patient’s needs, the bariatric procedure and severity of other comorbidities (7-8, 
15, 20, 33-34). 
Recommendation: All multidisciplinary bariatric surgery teams should follow-up patients at regular 
intervals post-surgery and offer a minimum of two year follow-up. 
Access should be available to appropriate healthcare professionals including surgeon, dietitian, 
nurse, clinical psychologist/psychiatrist and bariatric physician. 
Evidence: NCEPOD recommendation 
 
Appropriate tests (biochemical, haematological and nutritional) should be taken following the 
primary bariatric procedure.  Full details of the blood tests, including suggested timing and 
frequency, are in the BOMSS guidance but if any unexpected symptoms or problems occur, blood 
tests should be taken sooner (7-8, 15). If a patient has been vomiting excessively additional thiamine 
supplementation is recommended (35). At each patient encounter the NBSR database should be 
updated (1). 
Recommendation: Routine monitoring of biochemical, haematological and metabolic changes is 
recommended following bariatric surgery (BOMSS guidance)   





The majority of postoperative bariatric surgery patients do not need to be seen by a surgeon at each 
appointment, but by appropriately trained allied healthcare professionals who have easy access to a 
surgeon if required. The patient’s weight should be recorded. An enquiry into the resolution of 
weight related co-morbidities should be made and changes to medication and doses recorded. 
Checks should be made to ensure that patients are on the appropriate multivitamins and minerals 
for the surgery performed (15). Where there is any suspicion of post-operative complications such as 
a stricture or symptomatic hernia, the patient should be seen and assessed by the surgeon.  
Specialist bariatric dietitian 
The dietitian supports the patient to make the dietary, behavioural and lifestyle changes required to 
optimise nutrition and achieve the weight loss and metabolic goals. The level of support required 
varies between patients and may also be influenced by the surgical procedure. The majority of 
patients will require telephone review and support in the first few weeks, an initial 6 week review 
and then may require frequent appointments or reviews (for instance 4 to 6 weekly) in the first year. 
These may be face to face and by telephone. The frequency of follow-up may decrease in the second 
year. The patient needs access to robust support with the dietary, lifestyle and psychological 
changes required and some may require more support than others (2, 5, 36). The dietitian will assess 
the nutritional status, check compliance with vitamin and mineral supplements and provide advice 
on any additional nutritional and behaviour changes including additional supplements required. The 
bariatric dietitian usually has the most frequent contact with the patient and should have ready 
access to a surgeon/physician/clinical psychologist if there are any concerns. 
Recommendation: Bariatric specialist dietitians should support the patient and should have ready 
access to a bariatric surgeon/physician/clinical psychologist if there are any concerns.  
Evidence:  NICE and NCEPOD recommendations 
 
Specialist bariatric nurse 
The role of the bariatric nurse is to ensure coordinated care for the patient while in hospital. He/she 
liaises with supporting staff, ensures availability of appropriate equipment and trained staff to 
deliver safe and effective care to bariatric patients. The nurse provides specialist nursing care, 
support and advice to bariatric inpatient and outpatient care from assessment and throughout the 
pathway. He/she works as part of the multidisciplinary team to ensure patients are optimised for 
surgery. He/she also has a role in supporting patients’ information needs through educational group 
sessions and one to one discussions if required. Patients should be reviewed on the wards post-
surgery, telephoned within the first week of discharge to offer support and address any concerns, 
and then reviewed 2-3 weeks post-surgery. Medication, diet, wound care, physical activities, 
management of diabetes, hypertension and the use of CPAP should be discussed. The specialist 
bariatric nurse should give support to the nursing staff caring for bariatric patients to ensure policies 
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and protocols are adhered to and a high quality of evidence based care is delivered. Telephone 
contact is provided to patients in case of emergency. 
The specialist bariatric nurse may be trained in band adjustments and management (see gastric band 
surgery). 
Recommendation: Specialist bariatric nurse should be involved providing specialist nursing care, 
support and advice to bariatric inpatient and outpatient care from assessment and throughout the 
pathway. 
Evidence: GRADE D 
 
Access to clinical psychologists/psychiatrists/physician 
An assessment for the requirement of a bariatric physician and psychology/psychiatric input must be 
made and appropriate support provided should the patient require it (2, 37). Since many patients 
have multiple co-morbidities, ongoing review is still needed by the appropriate medical teams. 
Medication requirements may change. 
Where patients are receiving care for other medical or surgical conditions (e.g. cardiovascular 
disease, renal failure, epilepsy) communication with their specialist and general practitioner to keep 
them informed of progress is essential.  
Some patients may need additional support psychologically. Patients may struggle to adapt to the 
demands and pressures resulting from bariatric surgery. Access to additional counselling may be 
required. 
Recommendation: An assessment for the requirement of bariatric physician and clinical 
psychology/psychiatric input must be made and provided should the patient require it. 
Evidence: NCEPOD recommendation 
 
Gastric band surgery 
Depending on the make of gastric band that has been placed, the first band fill is usually undertaken 
between 4-6 weeks. Subsequent follow-up appointments should be every 4-6 weeks for the next 3-6 
months with reiteration of how the band functions, portion size, diet and food texture. Patients who 
have regular follow-up tend to have a greater weight loss than those who do not (8, 38-39). After 
this period, appointments for band reviews every 3-6 months should suffice, but with patients given 
clear instructions to get in contact sooner if there are symptoms that a band is too tight (such as 
dysphagia, vomiting, heartburn and nocturnal coughing). Patients with heartburn with a band in-situ 
have a tight band and need their bands deflating rather than being prescribed antacids or proton 
pump inhibitors. In some bariatric surgical services, the specialist bariatric nurse may do the gastric 
band adjustments undertaking a joint clinic with a specialist bariatric dietitian. 
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Recommendation: Patients need frequent follow-up following the placement of the gastric band 
until the optimal band fill is achieved.  
Gastric band patients should have annual follow-up indefinitely. 
Evidence: GRADE C 
 
Sleeve gastrectomy /gastric bypass / duodenal switch 
Within the bariatric surgical service, there is usually an initial follow-up at 6-8 weeks postoperatively, 
every three months for the first year, then every six months in the second year as a minimum (20). 
Patients may have additional appointments with the dietitian which may be face to face or by 
telephone.  
Recommendation: Within the bariatric surgical service, there should be an initial follow-up at 6-8 
weeks postoperatively, every three months for the first year, then every six months in the second 
year as a minimum. Continuity of care with ongoing support following bariatric surgery is essential 
for achievement of long term weight loss and metabolic goals. High risk patients such as duodenal 
switch or biliopancreatic diversion patients probably require lifelong follow-up in the specialist 
centre. 
Evidence: GRADE D 
 
Nutritional monitoring 
In addition to the dietetic assessment, patients will require lifelong nutritional monitoring to ensure 
that optimum nutrition is maintained. The bariatric multidisciplinary team should ensure that the 
appropriate monitoring takes place and that any abnormal investigational (biochemical, radiological) 
results or clinical issues are addressed (7-8, 15). Full details are available in the BOMSS “Guidelines 
on perioperative and postoperative biochemical monitoring and micronutrient replacement for 
patients undergoing bariatric surgery” (15). 
Recommendation: Patients should have lifelong nutritional monitoring to ensure optimum nutrition 
is maintained. 
Evidence: NICE recommendation 
 
Diabetes mellitus 
Type 2 diabetes mellitus (DM) in many patients may remit (achievement of acceptable glycaemia 
without medication) or control may improve following bariatric surgery. Monitoring of glycaemic 
status using fasting and postprandial capillary or venous glucose in the postoperative period is 
advised and this will require patients, even with type 2 diabetes to be able to undertake self-
monitoring and have access to glucose meters and measuring strips. The patients’ GPs should be 
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informed of the need for self-monitoring and prescription of measuring strips post-operatively. 
Patients should be discharged only from close perioperative follow-up after glycaemic status is well-
controlled on the advised dietary regimen with review at times of diet transition. HbA1c should not 
be used until the patient has stabilised after surgery. 
Remission of diabetes will be achieved in a large number of patients following bariatric surgery (40-
41). However, any triggers such as weight regain, pregnancy, severe infection or trauma should 
prompt the caring team to reassess glycaemic status and treat appropriately. Patients should remain 
on the practice diabetes register, and continue to be reviewed for micro and macrovascular 
complications of diabetes on an annual basis. There should be close communication between the 
bariatric and diabetes teams.  
Patients with Type 1 DM might also need to reduce doses of insulin due to improved insulin 
sensitivity and hence require regular follow-up based on individual patient need. 
Recommendation: Patients should be discharged only if acceptable glycaemic control on the advised 
dietary and pharmaceutical regimen with review at times of diet transition. Metformin should 
continue also contraindicated.  
Patients with diabetes mellitus should continue to be reviewed annually for micro and 
macrovascular complications of diabetes. 
Patients with Type 1 DM may need to reduce doses of insulin due to improved insulin sensitivity. 
Evidence: GRADE D  
 
Dumping syndrome and Post Prandial Hypoglycaemia (PPH) 
These occur after gastric bypass, but less commonly after duodenal switch and sleeve gastrectomy. 
Dumping syndrome refers to predominantly GI symptoms that occur early (10-30 minutes) after a 
meal often precipitated by ‘inappropriate’ foods. Patients should be advised on how to manage 
dumping syndrome and to adhere to the prescribed bariatric diet. 
PPH refers to hypoglycaemia with its associated symptoms that is often provoked by high glycaemic 
index foods or drinks resulting in hypoglycaemia typically 45-90 minutes after ingestion. This can be 
severe and even lead to loss of consciousness.  Both the patient and primary care physician should 
be educated about postprandial hypoglycaemia 
Nutritional intervention is the mainstay of dumping and PPH syndrome (small, frequent, low 
carbohydrate meals) (8). However, for hyperinsulinaemic hypoglycaemia, an urgent referral might be 
required to an endocrinologist for detailed investigations such as CT scan or selective arterial calcium 
stimulation test to exclude other causes and to consider pharmacological management if dietary 
advice is insufficient to control the problem. 
Recommendation:  Both the patient and primary care physician should be educated about 
postprandial hypoglycaemia after gastric bypass due to pancreatic beta cell hypertrophy which can 
occur several months to years after surgery.  
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Small frequent low glycaemic index meals are advised to treat both dumping and PPH syndromes. 
Further investigation and management of hypoglycaemia is needed if the patient fails to respond to 
dietary manipulation. 
Evidence: GRADE D 
 
Lipids 
Patients with dyslipidaemia and on lipid-modifying medications should be reassessed with fasting 
lipid profiles periodically. The liver shrinkage diet which is recommended up to four weeks prior to 
the bariatric surgery usually improves hypertriglyceridaemia.  Insulin sensitivity following bariatric 
surgery also aids in improving lipid profile particularly HDL cholesterol and triglycerides (42). Patients 
with familial hyperlipidaemias will need to remain on lipid lowering medications and under review of 
a lipid specialist to manage cardiovascular risk. Patients with high cardiovascular risk (i.e. QRISK2 
>10%) prior to surgery are likely to remain at high risk and should have their medication reviewed 
(43).  
Emphasis should be made for bariatric surgery patients with high cardiovascular risk regarding 
prevention of vitamin B12 deficiency by regular parenteral vitamin B12 injections (high risk patients 
include patients on proton pump inhibitors or metformin, as well as vegetarians) as vitamin B12 
deficiency is associated with variety of atherogenic processes (44). 
Recommendation: Patients with dyslipidaemia and on lipid modifying medications should be 
reassessed with fasting lipid profiles periodically including reassessment of cardiovascular risk status.  
Patients with familial hyperlipidaemias will need to remain on lipid lowering medications and under 
review of a lipid specialist to manage cardiovascular risk.  
Emphasis should be made for bariatric surgery patients with high cardiovascular risk regarding 
prevention of vitamin B12 deficiency by regular parenteral vitamin B12 injections. 
 Evidence: GRADE D 
 
Bone health 
Obese subjects have low vitamin D before surgery which is likely to be due to a combination of poor 
diet, poor absorption and a lack of skin exposure to natural sunlight. A systematic review shows that 
patients do not have their hypovitaminosis D corrected prior to surgery (45). Moreover, bone 
mineral density falls after obesity surgery (46). 
A randomised study of patients given loading doses of vitamin D before and maintenance doses 
after surgery showed that active treatment resulted in less bone loss (47). The current data do not 
offer adequate information to guide dosing (45) leading to conflicting advice in osteoporosis 
guidance (48). It should be noted that changes in vitamin D therapy require a minimum of three 
months before serum vitamin D concentrations stabilise (49). 
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A good oral intake of calcium is important. Following a gastric bypass, sleeve gastrectomy and 
duodenal switch BOMSS guidelines recommend additional calcium supplementation (15). This is 
usually a minimum of 800 to 1200 mg calcium for a sleeve gastrectomy and gastric bypass (15). 
More may be required following a duodenal switch. 
Patients who have had a gastric bypass, duodenal switch or biliopancreatic diversion may require 
dual-energy x-ray absorptiometry (DEXA) to monitor for osteoporosis (8, 18). 
Recommendation: All patients should have their vitamin D status assessed and treated prior to 
surgery and should have replacement prescribed after surgery. 
Evidence: GRADE B 
 
Medications 
Pharmacotherapies should be assessed and medications discussed with a pharmacist with 
consideration of altered pharmacokinetics and pharmacodynamics of drugs following bariatric 
surgery, e.g. sustained release medications might need to be substituted with immediate release 
medications. Patients will need liquid preparation of necessary drugs during the early postoperative 
period for example thyroxine, immunosuppressants, antipsychotics, anticonvulsants etc. (26). Some 
drugs might need to be substituted with alternative drugs or increased doses due to impact on their 
absorption site depending on the bariatric surgery type, e.g. decreased efficacy of lamotrigine, 
enalapril, ramipril, simvastatin, phenytoin, rifampicin, digoxin (50-51). Where possible monitoring of 
blood levels to ensure therapeutic levels are maintained is recommended. The primary care 
specialist should refer such cases if it is difficult to optimize patient. Generally patients who have had 
a gastric bypass are discharged on prophylactic proton pump inhibitors to help reduce marginal 
ulcers.  
Recommendation: Pharmacotherapies should be assessed and medications discussed with a 
pharmacist with careful consideration of altered pharmacokinetics and pharmacodynamics of drugs 
following bariatric surgery. Metformin should be continued unless contraindicated. 
Evidence: GRADE D  
 
There should be a review of patients at regular intervals to check metabolic status and to titrate 
correct doses of certain medications, e.g. thyroxine dose might need to be reduced following weight 
loss (53), absence of which can lead to cardiac complications in a patient with low cardiac reserve 
due to hypermetabolism.  
Patients on anti-coagulants, e.g. warfarin, low molecular heparin, should be managed by the 
bariatric multidisciplinary team (MDT) in conjunction with the anti-coagulation team, especially 
patients with a duodenal switch who are more likely to develop fat soluble vitamin deficiencies, e.g. 
Vitamin K (14). Detailed dietary advice about vitamin K content of foods and warfarin interaction 
should be provided to patients by the bariatric dietitian and anti-coagulation team. 
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Recommendation: Patients on anti-coagulants, e.g. warfarin, low molecular heparin, should be 
managed by the bariatric MDT in conjunction with the anti-coagulation team, especially patients 
with a duodenal switch who are more likely to develop fat soluble vitamin deficiencies. 
 Evidence: GRADE D  
 
Preconception and pregnancy 
Patients should be advised to avoid pregnancy for the first eighteen months following surgery by 
which time the patient is likely to be weight stable and able to consume a nutritionally balanced diet 
(8). Women with polycystic ovary syndrome should be advised that weight loss may result in 
increased fertility; therefore they need to use contraception to avoid an accidental pregnancy (8). 
Discussions around preconception vitamin and mineral supplements should take place, including the 
need for additional folic acid and avoiding supplements containing vitamin A in the retinol form (15). 
Preconception advice should be available to those women who are planning pregnancies (8, 15, 54-
55). During the preconception period, serum vitamin B12 should be measured along with folate 
before starting patients on folic acid as folic acid supplementation in a vitamin B12 deficient patient 
can lead to severe neurological complications (56). Robust communication with the antenatal team 
involving the patient should be established to allow combined care of the patient by imparting 
increased awareness to the antenatal team about the risk of nutritional deficiencies that the mother 
and foetus are exposed to due to bariatric surgery. Pregnant women require more frequent follow-
up and nutritional monitoring should be increased to every trimester (15, 31, 57-58). 
Recommendation: Women should have access to preconception counselling and advice regarding 
nutritional supplements and should be warned of the potential for increased fertility. 
Robust communication with the antenatal team should be established to increase awareness to the 
antenatal team about the risk of nutritional deficiencies that the mother and foetus are exposed to 
due to bariatric surgery.  Pregnant women require more frequent follow-up and nutritional 
monitoring should be increased to every trimester. 
Evidence: GRADE D 
 
Pre-existing mental health conditions 
Patients with pre-existing mental health conditions may need review of their condition including 
medication reviews (50-52). Some medications may be associated with increased appetite and thirst. 
Patients may need additional psychological/psychiatric support and there should be good 
communication with the patient’s psychologist /psychiatrist. 
Recommendation: Patients with pre-existing mental health conditions may need medication 
reviews.  




 Access to psychological support 
Inevitably in the longer term, some patients will experience weight regain or return of obesity 
related comorbidities and may struggle psychologically with this. There are also reports of some 
patients presenting with addiction transfer, alcohol and substance misuse or increased risk of suicide 
(60-62). Psychological support should be available.  
Recommendation: Some patients may struggle psychologically, experience addiction transfer, 
alcohol and substance misuse or have an increased risk of suicide. Psychological support should be 
available. 
Evidence: GRADE D  
 
Advice on physical activity and exercise 
As patients lose weight, they may need support and encouragement to become more physically 
active (8). Some will benefit from referral to specialist physiotherapy or specialist exercise 
programmes. 
Recommendation: As patients lose weight, they may need support and encouragement to become 
more physically active. Some will benefit from referral to specialist physiotherapy or specialist 
exercise programmes. 
Evidence: GRADE D  
 
Patient groups who may require more frequent follow-up and support 
Some patient groups may require more frequent follow-up because of their higher risk of metabolic 
and biochemical complications. These include: 
• Women who become pregnant (31, 63) or who are breastfeeding (64) 
• Women with menorrhagia (iron deficiency anaemia) (65) 
• Patients on proton pump inhibitors and metformin* (B12 deficiency) (66) 
• Patients who have had duodenal switch surgery (greater risk of protein malnutrition and fat 
soluble vitamins deficiency) (11, 14) 
• Patient with co-existing malabsorptive conditions such as coeliac disease*, tropical sprue, 
inflammatory bowel disease 
• Patients with renal impairment* or single kidney, kidney stones (67)  
• Transplant patients*  
• Patients who are immobile or who are wheelchair users 
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• Patients on thyroxine or multiple myeloma* patients (high bone turnover likely) 
• Patients with high cardiovascular risk* (should not be given high calcium doses) 
• Patients with previous history of binge eating disorder  
• Patients with psychiatric conditions* 
* Many of these patients will be under the care of other medical professions and it is important to 
maintain good communication with other healthcare professionals kept informed. 
Recommendation: Some patient groups may require more frequent follow-up because of their 
higher risk of metabolic and biochemical complications (see above). Many of these patients will be 
under the care of other medical professions and it is important to maintain good communication 
with other healthcare professionals kept informed. 
 Evidence: GRADE C 
 
Patients who do not attend follow-up 
Unfortunately, a small number of patients may not attend their follow-up appointments. This is of 
concern as these patients may be vulnerable to long term clinical and nutritional problems. Bariatric 
surgical services should set up a system to minimise the risk that patents are lost to follow-up. If a 
patient persistently does not attend for follow-up, the bariatric centre should contact the GP and put 
their concerns in writing to both the GP and patient. The GP and, importantly, the patient must be 
informed of the need for continued nutritional monitoring and compliance with vitamin and mineral 
supplements. 
Recommendation: Bariatric surgical services should set up a system to minimise the risk that patents 
are lost to follow-up. 
 If a patient persistently does not attend for follow-up, the bariatric surgical services should contact 
the GP and put their concerns in writing to both the GP and patient. The GP and, importantly, the 
patient must be informed of the need for continued nutritional monitoring and compliance with 
vitamin and mineral supplements. 
Evidence: GRADE D 
 
Access to patient support groups  
Many patients benefit from peer support (8). Patients should have been advised prior to surgery of 
local patient support groups and online forums and websites such as http://www.wlsinfo.org.uk/ 
and http://www.bospauk.org/  
Recommendation: Patients should have been advised prior to surgery of local patient support 
groups, online forums and websites. 




When should the primary care physician refer back in early stages? 
The assessment of the obese patient is difficult following recent bariatric surgery and primary care 
physicians should have a low index of suspicion that something is not right and refer in a timely and 
appropriate manor (See BOMSS poster available at http://www.bomss.org.uk/wp-
content/uploads/2014/04/ED_Poster_Complications_Version_6.pdf) (68). 
 
Serious problems within the first two weeks include: 
• Acute renal failure 
• Abdominal pain, tachycardia and pyrexia. This may indicate a leak or iatrogenic bowel injury 
until proved otherwise and requires emergency admission 
• Chest pain, shortness of breath and tachypnoea. This may indicate a pulmonary embolus 
until proved otherwise and requires emergency admission 
• Unilateral or bilateral swollen legs. This may indicate a DVT 
• Continuous vomiting, with or without abdominal pain. This may indicate an over tight or 
slipped gastric band, stenotic anastomosis, kinked gastric sleeve or a bowel obstruction until 
proved otherwise and requires emergency admission 
• Following the insertion of a gastric band a wound infection associated with the port site 
should be taken seriously. Some surgeons are happy to remove the infected port, tie off the 
tubing and wait for all signs of infection to pass before replacing the port. Other surgeons 
believe that the whole prosthesis is infected and will remove it all. 
Less serious problems within the first two weeks include: 
• Dehydration with resulting constipation which is common post bariatric surgery. Little and 
often is encouraged with respect to fluid intake to achieve an intake of 2 litres a day 
• Patients with a gastric balloon will feel awful for a week with nausea and vomiting. Most 
settle, but occasionally may need to be admitted for intravenous fluids 
• Bruising/haematomas at the port sites. 
 
Discharge from bariatric surgical service after 2 years 
In England, patients must be followed-up in the bariatric surgical service for a minimum of two 
years. Patients must receive long term follow-up (3) and there are a number of suggested shared 
care models included in the appendices of this article. Clinical problems such as chronic diarrhoea or 
severe reactive hypoglycaemia should be addressed before the patient’s care is transferred. The 
patient may need continued support from the bariatric dietitian if they are still struggling with the 
nutritional balance of the diet or continued weight loss. It may be appropriate for duodenal switch 
patients to receive lifelong follow-up from the bariatric surgical service. Once discharged from the 
bariatric surgical service, patients should all have a yearly follow-up by appropriately trained health 
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professionals who will check the patient’s weight, multivitamin and mineral supplementation, 
annual blood tests and enquire about the resolution of weight related co-morbidities. Ideally this 
information should be relayed back to the bariatric surgical service to add onto the NBSR. At any 
stage, if there are clinical concerns or help is required to interpret investigation the bariatric surgical 
service should be contacted. 
Recommendation: Following discharge from the bariatric surgical service, all patients should have a 
yearly follow-up by appropriately trained health professionals (see later for details of recommended 
annual review). 
Evidence: GRADE D 
 
At discharge, the focus is on weight maintenance rather than continued weight loss. Before 
discharge the patient should be supported to develop skills which will help with weight 
maintenance. Continued food monitoring, regular weight checks, balanced diet and increased 
activity are all key components of weight management strategies. 
 
Final discharge letters to primary care at two years 
The discharge letters must contain full details of the following: bariatric procedure, emergency 
contact numbers, annual blood tests required, long term vitamins and minerals supplements, life 
style modifications and a list of symptoms which may indicate late surgical complications that would 
warrant referral back to the bariatric surgical service (appendix 1).  Letters should be sent to the GP 
and the patient. 
Recommendation: Discharge letters must contain full details of the following: bariatric procedure, 
emergency contact numbers, annual blood tests required, long term vitamins and minerals 
supplements, life style modifications and when to refer back. Letters should be sent to the GP and 
the patient. 
Evidence: Grade D 
 
Long term follow-up 
NICE CG189 (obesity)  recommends that after discharge from bariatric surgical service follow-up that 
all patients are offered at least annual monitoring of nutritional status and appropriate 
supplementation according to need following bariatric surgery, as part of a shared care model of 
chronic disease management (3).  
Long term monitoring 
Monitoring should include the following: 
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• Assessment of nutritional intake (7-8, 12) 
• Nutritional monitoring (3, 7-8, 12, 15)  
• Weight check 
• Assessment of co-morbidities 
• Review of multivitamin and mineral supplements (check compliance)  
• Investigation of abnormal results and appropriate treatment as required (7-8, 15) 
• Review of potential concerning symptoms such as vomiting and heartburn. 
Recommendation: Annual review should include an assessment of nutritional intake, nutritional 
monitoring, weight check, assessment of co-morbidities, review of multivitamin and mineral 
supplements and investigation of abnormal results and appropriate treatment as required.   
Evidence: GRADE C  
 
Some patients may have excess skin because of the weight loss resulting in physical discomfort, 
decreased mobility and psychosocial problems (33, 69). Consideration for plastic /reconstruction 
surgery should be given. 
Recommendation: Information on, or access to, plastic surgery (such as apronectomy) should be 
given when appropriate.   
Evidence: NICE recommendation 
 
Many patients will experience some weight regain and this is perfectly normal. However, it is 
extremely disheartening and may cause anxiety. Patients should be encouraged to maintain lifestyle 
changes, monitor food intake, have regular weight checks and be active. Some patients may benefit 
from a review with the specialist bariatric dietitian, or enrolment and attendance at a community 
based weight management groups. Where there is excessive weight gain, consideration should be 
given to referring the patient back to Tier 3 for assessment if there are no accompanying surgical red 
flags.  
Recommendation: Patients should be encouraged to maintain lifestyle changes, monitor food intake, 
have regular weight checks and be physically active.  Where there is excessive weight gain, 
consideration should be given to referring the patient back to Tier 3 for assessment if there are no 
accompanying surgical red flags. 
Evidence: GRADE D 
 
Overview of shared care protocols for the management of post bariatric surgery patients 
Whilst the concept of shared care is new to bariatric surgical service, the principle is established in 
other areas for example monitoring rheumatology second line medications. The choice of model will 
be dependent on local commissioning choices, resources and available skill sets. They may include 
variations for different surgical options. For instance gastric band refills may be done in secondary 
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care settings, and people with very complex operations such as biliopancreatic diversion (BPD) or 
duodenal switch may need permanent follow-up within an expert bariatric surgical service or 
specialist obesity Tier 3 service. 
In all the models presented in this article, the specialist centres could be co-located at the original 
bariatric surgical unit, a local hospital based Tier 3 service, or a community based Tier 3 service, 
depending on the local commissioners and availability of services. 
The bariatric surgical services are required to submit long term follow-up data to the National 
Bariatric Surgery Register (NBSR) (1-2). This will include the NHS number from late 2015. It is 
important that whoever sees the patient at follow-up appointments completes the appropriate form 
and returns it to the original surgical unit for submission to the NBSR database. 
This document refers to NHS operations, but private surgical providers should be responsible for 
organising appropriate follow-up and sending the patient’s GP the appropriate guidance. 
Recommendation: After discharge from the bariatric surgical service, follow-up all patients should be 
offered at least annual review, including monitoring of nutritional status and appropriate 
supplementation according to need, as part of a shared care model of chronic disease management. 
Evidence: GRADE D   
Possible models of care 
Model 1: GP annual blood tests and co-morbidities review model 
In this model, the patient’s care is shared between the specialist centre and the GP. This ensures 
that the patient has access to specialist advice and support. Capacity would need to be built into the 
specialist centres to accommodate annual reviews. Both the GP and the specialist centres need 
robust systems to ensure annual reviews take place. 
Model 2: GP annual blood tests and co-morbidities review plus model 
In this model, the patient is followed up by GP only, with an annual nutritional review provided by 
the Tier 3 dietitian (and referral back if necessary). This nutritional review may be via a face to face, 
telephone, postal or electronic consultation. The GP needs a robust system to ensure the review 
takes place and timely information is sent to the specialist centre. The GP would also be charged 
with the responsibility of forwarding appropriate data back to the original surgical unit for entry to 
the NBSR. 
Model 3: Specialist follow-up model 
In this model, the patient is followed up by specialist team (usually a local Tier 3 service). There 
needs to be a robust recall system and the service must be commissioned and funded to enable 
annual review. There needs to be good communication with the GP. If the patient moves out of area, 
the care may need to be passed onto another specialist team. The specialist centre sends data to the 
original surgical unit for entry onto the NBSR. 
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Model 4: Joint appointments in primary care model 
In this model, the patient is followed up jointly by specialist team and GP in the community. This 
ensures that the patient has access to specialist advice and support. Capacity would need to be built 
into the specialist centres staffing to accommodate annual reviews. Both the GP and the specialist 
centres need robust systems to ensure annual reviews take place. This enables knowledge and skills 
to be shared and may be more convenient for the patient.  The specialist centre sends data to the 
original surgical unit for entry into the NBSR. 
Full details of each shared care model are available in Appendix 2. 
When should GPs refer back in later stages? 
Most patients will be getting on with their lives with no issues associated with their bariatric surgery. 
However, problems can arise later and may require further investigation and referral back to the 
bariatric surgical service. These are detailed in Appendix 1. 
Recommendation: Primary care physicians should be aware of potential long term problems (37) 
following bariatric surgery (Appendix 1) and refer back to the bariatric surgical service appropriately.  
Evidence: GRADE D 
 
3. Recommendations for future development of service 
All patients should receive comprehensive and lifelong follow-up and monitoring after bariatric 
surgery to support them in achieving an improvement in co-morbidities and prevent any long term 
bariatric surgery related problems (7-8, 12, 15-16, 18). In England, Clinical Commissioning Groups are 
responsible for ensuring that long term follow-up is provided for patients using one of the shared 
care models in Appendix 2. 
Recommendation: Clinical commissioning groups should adopt one of the proposed shared care 
models and invest in the local infrastructure and training of health care professionals in the 
management of bariatric surgery patients. 
Evidence: GRADE D 
 
Each of the models will require investment in local infrastructure. Training and up-skilling of GP, 
dietitians and other primary care staff in the management of bariatric surgery patients are needed 
(37). 




More healthcare professionals are coming into contact with patients who have had bariatric surgery. 
This includes staff working in emergency departments, obstetricians, midwives and dietitians. E-
learning modules on the management of bariatric surgery patients need to be developed and 
available.  
Recommendation: Health care professionals need to have an awareness of potential complications 
post bariatric surgery and refer back to the bariatric team in a timely and appropriate manner.  
Continuing professional development education modules should be developed (26, 33).  
Evidence Grade D 
 
Recommendation: Healthcare professionals including obstetricians, midwives, dietitians and 
emergency department staff need training in the management of bariatric surgery patients. This 
could be in the form of e-learning modules. 
Evidence: GRADE D 
 
All emergency departments need to be aware of the management of bariatric patients who may 
present to the department. This includes managing band deflations if appropriate. A video on band 
deflation should be developed. 
Recommendation: Emergency staff should be knowledgeable about the management of bariatric 
surgery patients who may present to the department including the management of gastric bands 
and band deflations. 
Evidence: GRADE D 
 
A medic alert bracelet or bariatric alert card could be used by patients.  This would provide 
information to the acute team if a patient is brought to hospital in an unconscious state/unable to 
explain the bariatric surgery and medications he/she is on. An example of the information required 
is contained in Appendix 3. 
Recommendation: A medic alert bracelet or a bariatric alert card providing details of the bariatric 
procedure and medications should be available for patients.  
Evidence: GRADE D 
 
Alternatives ways to facilitate long term follow-up and collection of data for NBSR should be 
explored including electronic food diaries, Skype and telephone consultations. 
Recommendation: Alternative ways of collecting long term data for NBSR should be explored. 
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Evidence: GRADE D 
4. Conclusions 
For those patients with severe and complex obesity, bariatric surgery is a useful tool along with diet 
and lifestyle changes in aiding weight loss and improvements in co-morbidities. It is essential that 
patients receive long term follow-up and monitoring to achieve these goals, maintain the 
improvements in co-morbidities and weight and prevent long term problems which may arise 
following surgery. Access to bariatric surgical services and specialist teams varies across the country; 
therefore four different shared care models have been proposed. Clinical commissioning groups 
need to ensure that a shared care model is implemented to ensure that patient safety and long term 
follow-up are maintained. This will raise challenges with the need for investment in follow-up 
protocols, training and development of staff, input into NBSR and the funding required to support 
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